Literature DB >> 8555802

Improved survival in homozygous sickle cell disease: lessons from a cohort study.

A Lee1, P Thomas, L Cupidore, B Serjeant, G Serjeant.   

Abstract

OBJECTIVE: To examine whether simple interventions in a sickle cell clinic improve survival in sickle cell disease.
DESIGN: Survival curve analysis and hazard ratios in a cohort study followed from birth.
SETTING: MRC Laboratories (Jamaica) at the University of the West Indies, and Victoria Jubilee Hospital, Kingston, Jamaica.
SUBJECTS: 315 patients with homozygous sickle cell disease detected during the screening of 100,000 consecutive non-operative deliveries between June 1973 and December 1981 at the main government maternity hospital, Kingston, Jamaica.
INTERVENTIONS: Prophylactic penicillin to prevent pneumococcal septicaemia, parental education in early diagnosis of acute splenic sequestration, close monitoring in sickle cell clinic. MAIN OUTCOME MEASURES: Survival.
RESULTS: Survival appeared to improve, the log rank test for trend comparing the first, second, and last third of the study reaching borderline significance (P = 0.05). Combined deaths from acute splenic sequestration and pneumococcal septicaemia-meningitis declined significantly (test for trend, P = 0.02).
CONCLUSION: Early diagnosis and simple prophylactic measures significantly reduce deaths associated with homozygous sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8555802      PMCID: PMC2551498          DOI: 10.1136/bmj.311.7020.1600

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

Review 1.  Bone marrow transplantation for sickle cell anemia: summarizing comments.

Authors:  E Beutler
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

2.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

3.  Beneficial effect of blood transfusion in children with sickle cell chest syndrome.

Authors:  A A Mallouh; M Asha
Journal:  Am J Dis Child       Date:  1988-02

4.  Causes of death in sickle-cell disease in Jamaica.

Authors:  A N Thomas; C Pattison; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

5.  Prevention of pneumococcal infection in children with homozygous sickle cell disease.

Authors:  A B John; A Ramlal; H Jackson; G H Maude; A W Sharma; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

6.  Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.

Authors:  G R Serjeant; J M Topley; K Mason; B E Serjeant; J R Pattison; S E Jones; R Mohamed
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

7.  Bone marrow transplantation for severe sickle cell anaemia.

Authors:  A Ferster; C De Valck; N Azzi; P Fondu; M Toppet; E Sariban
Journal:  Br J Haematol       Date:  1992-01       Impact factor: 6.998

8.  Acute splenic sequestration in homozygous sickle cell disease: natural history and management.

Authors:  A M Emond; R Collis; D Darvill; D R Higgs; G H Maude; G R Serjeant
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

9.  Prepubertal growth and skeletal maturation in children with sickle cell disease.

Authors:  M C Stevens; G H Maude; L Cupidore; H Jackson; R J Hayes; G R Serjeant
Journal:  Pediatrics       Date:  1986-07       Impact factor: 7.124

10.  Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival.

Authors:  D Powars; G Overturf; J Weiss; S Lee; L Chan
Journal:  JAMA       Date:  1981-05-08       Impact factor: 56.272

View more
  48 in total

1.  Costing model for neonatal screening and diagnosis of haemoglobinopathies.

Authors:  E K Cronin; C Normand; J S Henthorn; M Hickman; S C Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality.

Authors:  Scott D Grosse; Hani K Atrash; Isaac Odame; Djesika Amendah; Frédéric B Piel; Thomas N Williams
Journal:  Am J Prev Med       Date:  2012-06       Impact factor: 5.043

3.  A 19-year-old woman with sickle cell disease and pain.

Authors:  Richard Ward; Ewurabena Simpson; Madeleine Verhovsek
Journal:  CMAJ       Date:  2016-02-01       Impact factor: 8.262

Review 4.  Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities.

Authors:  Sharada A Sarnaik
Journal:  Pediatr Radiol       Date:  2005-02-10

5.  Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany.

Authors:  Stephan Lobitz; Claudia Frömmel; Annemarie Brose; Jeannette Klein; Oliver Blankenstein
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

Review 6.  The natural history of sickle cell disease.

Authors:  Graham R Serjeant
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

7.  Newborn screening for sickle cell disease in India: the need for defining optimal clinical care.

Authors:  Jyotish Patel; Graham R Serjeant
Journal:  Indian J Pediatr       Date:  2013-09-14       Impact factor: 1.967

8.  Understanding pain and improving management of sickle cell disease: the PiSCES study.

Authors:  Wally R Smith; Viktor E Bovbjerg; Lynne T Penberthy; Donna K McClish; James L Levenson; John D Roberts; Karen Gil; Susan D Roseff; Imoigele P Aisiku
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

9.  Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.

Authors:  Y M Agble
Journal:  BMJ       Date:  1998-03-21

10.  Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

Authors:  M E Kizito; E Mworozi; C Ndugwa; G R Serjeant
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.